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Editorial
New frontiers in nuclear cardiology
T he field of cardiovascular disease diagnosis and management is moving at a very rapid pace. Different diagnostic tools have been invented, some of them measuring the same thing using 
different physiologic principles and technology. As such, 
scientists are continuously looking for new applications 
for already available diagnostic tools. Thanks to that 
pursuit led by restless investigators, we can now have 
more sensitive and specific stress tests with the use of 
myocardial perfusion imaging. In this number of  Medicina 
Universitaria there are two articles addressing new uses 
of nuclear cardiology imaging. One study1 addresses the 
clinical relevance of ST depression in the electrocardio-
gram in the recovery phase of an exercise stress test by 
assessing perfusion abnormalities in subjects undergoing 
a nuclear stress test to diagnose myocardial ischemia. ST 
depression during the recovery phase has been considered 
by some as a sign of myocardial ischemia and for others a 
mere paraphenomenon without clear clinical significance. 
In this study by De La Peña-Almaguer et al, the prevalence 
of abnormalities suggesting ischemic changes or fixed 
defects suggesting old myocardial infarction was elevated, 
suggesting that ST depression during recovery may not 
be considered a benign finding. It is not clear if that high 
prevalence of nuclear isotope uptake abnormalities was 
higher, lower or the same than the prevalence found in 
patients with ST depression during exercise. More impor-
tantly, it is not clear if the prevalence of such abnormalities 
was higher in the study group than in those subjects with a 
high pretest probability of CAD but had no ECG changes 
at all. Further investigation is needed to clarify the relative 
importance of the findings by Dr. De La Peña. 
The second study assessed the diagnostic value of 
myocardial perfusion tests, specifically using Tc-99 
tetrofosmin-gated SPECT, to detect left ventricular hy-
pertrophy.2 The results were not very encouraging. The 
sensitivity of this myocardial perfusion test was too low 
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to guarantee any clinical value, despite the excellent spe-
cificity of the test to detect hypertrophy. The results were 
not necessarily surprising. Images derived from nuclear 
perfusion scans have a low resolution with a discriminatory 
power in the range of 5-10 mm, much lower than echocar-
diography where the resolution is in the range of 2 mm. 
Furthermore, is it unlikely that clinicians suspecting left 
ventricular hypertrophy would request a nuclear scan to 
diagnose it. However, patients without a medical history of 
hypertrophy, particularly those with no previous echocar-
diogram who are found to have hypertrophy in a nuclear 
scan may need further cardiac evaluation. As noted in the 
manuscript, the presence of left ventricular hypertrophy 
increases the risk for cardiovascular events. Patient with 
this abnormality require an aggressive management of risk 
factors, tight blood pressure response if hypertension was 
the cause of the hypertrophy, or further cardiac evaluation 
if the hypertrophy occurs in the absence of hypertension. 
Hypertrophic cardiomyopathy would be a disease to rule 
out, as some patients with this condition are at high risk 
for sudden death. 
Dr. De La Peña deserves to be congratulated for publis-
hing these two clinical studies that will help us clarify the 
expanded utility and limitations of nuclear cardiology.
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